Sharon Cohen

6.5k total citations · 1 hit paper
45 papers, 3.7k citations indexed

About

Sharon Cohen is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Sharon Cohen has authored 45 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 11 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Sharon Cohen's work include Alzheimer's disease research and treatments (14 papers), Cholinesterase and Neurodegenerative Diseases (11 papers) and Dementia and Cognitive Impairment Research (9 papers). Sharon Cohen is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Cholinesterase and Neurodegenerative Diseases (11 papers) and Dementia and Cognitive Impairment Research (9 papers). Sharon Cohen collaborates with scholars based in United States, Israel and Canada. Sharon Cohen's co-authors include Christopher H. van Dyck, Paul Aisen, David Watson, Takeshi Iwatsubo, Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer, Chad J. Swanson, Randall J. Bateman and Michelle Gee and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Neurology.

In The Last Decade

Sharon Cohen

44 papers receiving 3.6k citations

Hit Papers

Lecanemab in Early Alzheimer’s Disease 2022 2026 2023 2024 2022 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lecanemab in Early Alzheimer’s Disease
    2022 2.7k citations Christopher H. van Dyck, Chad J. Swanson et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Cohen United States 15 1.8k 996 840 564 547 45 3.7k
Ana Frank Spain 34 1.9k 1.1× 1.2k 1.2× 956 1.1× 489 0.9× 760 1.4× 100 4.4k
Michael S. Rafii United States 33 1.7k 1.0× 1.3k 1.3× 979 1.2× 470 0.8× 599 1.1× 112 4.8k
Simone Lista France 40 2.5k 1.4× 1.6k 1.6× 1.4k 1.6× 392 0.7× 771 1.4× 126 4.7k
Xiaoyan Sun United States 33 2.4k 1.3× 623 0.6× 1.3k 1.6× 557 1.0× 593 1.1× 86 4.1k
Wei Qiao Qiu United States 36 2.9k 1.6× 821 0.8× 1.9k 2.2× 664 1.2× 749 1.4× 114 5.8k
C. Hock Switzerland 24 1.5k 0.9× 434 0.4× 614 0.7× 517 0.9× 634 1.2× 39 3.6k
Mirosław Bryś United States 27 2.3k 1.3× 1.3k 1.3× 666 0.8× 295 0.5× 711 1.3× 47 3.9k
Abdul Hye United Kingdom 32 1.9k 1.1× 923 0.9× 1.3k 1.5× 185 0.3× 540 1.0× 83 3.4k
Lin Tan China 31 1.6k 0.9× 1.2k 1.2× 1.5k 1.8× 254 0.5× 836 1.5× 85 4.6k
Benedetta Nacmias Italy 39 2.2k 1.2× 1.3k 1.3× 1.7k 2.0× 359 0.6× 632 1.2× 212 5.3k

Countries citing papers authored by Sharon Cohen

Since Specialization
Citations

This map shows the geographic impact of Sharon Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Cohen more than expected).

Fields of papers citing papers by Sharon Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Cohen. The network helps show where Sharon Cohen may publish in the future.

Co-authorship network of co-authors of Sharon Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Cohen. A scholar is included among the top collaborators of Sharon Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Cohen. Sharon Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Mohs, Richard C., Sharon Rosenzweig‐Lipson, Michael Rosenblum, et al.. (2024). The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(1). e12446–e12446. 15 indexed citations
4.
Cohen, Sharon, Jeffrey L. Cummings, Wiesje M. van der Flier, et al.. (2024). Defining benefit: Clinically and biologically meaningful outcomes in the next‐generation Alzheimer's disease clinical care pathway. Alzheimer s & Dementia. 21(2). e14425–e14425. 3 indexed citations
5.
Cohen, Sharon, Simon Ducharme, Jared R. Brosch, et al.. (2023). Interim phase 1 part A results for ALN‐APP, the first investigational RNAi therapeutic in development for Alzheimer’s disease. Alzheimer s & Dementia. 19(S24). e082650–e082650. 8 indexed citations
6.
Dyck, Christopher H. van, Chad J. Swanson, Paul Aisen, et al.. (2022). Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine. 388(1). 9–21. 2741 indexed citations breakdown →
7.
Aisen, Paul, Frederik Barkhof, Carmen Castrillo‐Viguera, et al.. (2022). ENVISION: A phase 3b/4 randomized, double‐blind, placebo‐controlled, parallel‐group study to verify the clinical benefit of aducanumab in participants with early Alzheimer’s disease. Alzheimer s & Dementia. 18(S10). 3 indexed citations
8.
Cohen, Sharon, Christopher H. van Dyck, Catherine J. Mummery, et al.. (2022). Baseline EMBARK Data From EMERGE, ENGAGE, and PRIME Participants in the EMBARK Redosing Study (N3.002). Neurology. 98(18_supplement). 1 indexed citations
9.
Dotan, Dror, et al.. (2020). Serial and syntactic processing in the visual analysis of multi-digit numbers. Cortex. 134. 162–180. 9 indexed citations
10.
Edel, Yonatan, Rivka Mamet, Sharon Cohen, et al.. (2020). The clinical importance of early acute hepatic porphyria diagnosis: a national cohort. Internal and Emergency Medicine. 16(1). 133–139. 8 indexed citations
11.
Czarnuch, Stephen, et al.. (2013). A real-world deployment of the COACH prompting system. Journal of Ambient Intelligence and Smart Environments. 5(5). 463–478. 23 indexed citations
12.
Landen, Jaren W., Qinying Zhao, Sharon Cohen, et al.. (2013). Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease. Clinical Neuropharmacology. 36(1). 14–23. 65 indexed citations
13.
Cohen, Sharon, Ilan Bruchim, Varda Oron‐Karni, et al.. (2012). Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. Journal of Molecular Medicine. 91(3). 357–368. 76 indexed citations
14.
Cohen, Sharon, Joseph Haimovich, & Nurit Hollander. (2012). Distinct processing of the pre-B cell receptor and the B cell receptor. Molecular Immunology. 54(2). 115–121. 1 indexed citations
15.
Raviv, Ziv, et al.. (2012). The anti-cancer activities of jasmonates. Cancer Chemotherapy and Pharmacology. 71(2). 275–285. 43 indexed citations
16.
Cohen, Sharon, Joseph Haimovich, & Nurit Hollander. (2009). Dendritic Cell-Based Therapeutic Vaccination against Myeloma: Vaccine Formulation Determines Efficacy against Light Chain Myeloma. The Journal of Immunology. 182(3). 1667–1673. 27 indexed citations
17.
Cohen, Sharon & Eliezer Flescher. (2009). Methyl jasmonate: A plant stress hormone as an anti-cancer drug. Phytochemistry. 70(13-14). 1600–1609. 112 indexed citations
18.
Cohen, Sharon, Joseph Haimovich, & Nurit Hollander. (2005). B-Cell Lymphoma and Myeloma Protection Induced by Idiotype Vaccination with Dendritic Cells Is Mediated Entirely by T Cells in Mice. Journal of Immunotherapy. 28(5). 461–466. 14 indexed citations
19.
Cohen, Sharon, Joseph Haimovich, & Nurit Hollander. (2003). Anti-idiotype × Anti-LFA-1 Bispecific Antibodies Inhibit Metastasis of B Cell Lymphoma. The Journal of Immunology. 170(5). 2695–2701. 17 indexed citations
20.
Fowler, James A. & Sharon Cohen. (1983). A method for the quantitative collection of ectoparasites from birds. Ringing & Migration. 4(3). 185–189. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Frank Breakdown of academic impact, for papers by Michael S. Rafii Breakdown of academic impact, for papers by Simone Lista Breakdown of academic impact, for papers by Xiaoyan Sun Breakdown of academic impact, for papers by Wei Qiao Qiu Breakdown of academic impact, for papers by C. Hock Breakdown of academic impact, for papers by Mirosław Bryś Breakdown of academic impact, for papers by Abdul Hye Breakdown of academic impact, for papers by Lin Tan Breakdown of academic impact, for papers by Benedetta Nacmias
Rankless by CCL
2026